THANH NGUYEN: Open Payments
NPI 1518572007 · ALHAMBRA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$828 in 50 payments from 8 companies in 2025. Trend: 2023 $513 · 2024 $1,380 · 2025 $828
Food & beverage: $828
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 34 | $352 |
| AstraZeneca Pharmaceuticals LP | 8 | $275 |
| GlaxoSmithKline, LLC. | 2 | $47 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| Globus Medical, Inc. | 1 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $32 |
| Lilly USA, LLC | 1 | $25 |
| Novo Nordisk Inc | 1 | $19 |
Products named: OTEZLA, AIRSUPRA, TRELEGY ELLIPTA, BREZTRI, Senza, JARDIANCE, MOUNJARO, CAPVAXIVE.
Industry payments across CA — which companies pay providers there.
